Cargando…

Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia

OBJECTIVE: To study the pattern of psychotropic medication use and compare this pattern between inpatient and outpatient psychiatric settings in Saudi Arabia. METHOD: This cross-sectional observational study was conducted between July 2012 and June 2014 on patients seeking psychiatric advice at majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alosaimi, Fahad D, Alhabbad, Abdulhadi, Abalhassan, Mohammed F, Fallata, Ebtihaj O, Alzain, Nasser M, Alassiry, Mohammad Zayed, Haddad, Bander Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844432/
https://www.ncbi.nlm.nih.gov/pubmed/27143891
http://dx.doi.org/10.2147/NDT.S100405
_version_ 1782428772008460288
author Alosaimi, Fahad D
Alhabbad, Abdulhadi
Abalhassan, Mohammed F
Fallata, Ebtihaj O
Alzain, Nasser M
Alassiry, Mohammad Zayed
Haddad, Bander Abdullah
author_facet Alosaimi, Fahad D
Alhabbad, Abdulhadi
Abalhassan, Mohammed F
Fallata, Ebtihaj O
Alzain, Nasser M
Alassiry, Mohammad Zayed
Haddad, Bander Abdullah
author_sort Alosaimi, Fahad D
collection PubMed
description OBJECTIVE: To study the pattern of psychotropic medication use and compare this pattern between inpatient and outpatient psychiatric settings in Saudi Arabia. METHOD: This cross-sectional observational study was conducted between July 2012 and June 2014 on patients seeking psychiatric advice at major hospitals in five main regions of Saudi Arabia. Male (n=651) and female (n=594) patients who signed the informed consent form and were currently or had been previously using psychotropic medications, irrespective of the patient’s type of psychiatric diagnosis and duration of the disease, were included. A total of 1,246 patients were found to be suitable in the inclusion criteria of whom 464 were inpatients while 782 were outpatients. RESULTS: Several studied demographic factors have shown that compared with outpatients, inpatients were more likely to be male (P=0.004), unmarried (P<0.001), have less number of children (1–3; P=0.002), unemployed (P=0.001), have a lower family income (<3,000 SR; P<0.001), live in rural communities (P<0.001), have a lower body mass index (P=0.001), and are smokers (P<0.001); however, there were no differences with regard to age or educational levels. The current frequency of use of psychotropic medications in overall patients was antipsychotics (76.6%), antidepressants (41.4%), mood stabilizers (27.9%), and antianxiety (6.2%). However, compared to outpatients, the current use of medications for inpatients was more frequent (93.8% vs 89.9%, P=0.019) with inpatients more likely to be treated with multiple medications (2.1 vs 1.8 medications). A similar trend was observed in the case of antipsychotics, high potency first-generation antipsychotics, second-generation antipsychotics, mood stabilizers, and antianxiety medicines where inpatients were more frequently treated with these medications for all psychiatric diagnoses when compared with outpatients. On the contrary, in the case of antidepressant treatment, an opposite trend was observed with more number of treated outpatients in comparison to inpatients. Among elderly patients, 75.9% received antipsychotics, mainly second-generation formulations (67.2%), whereas only 41% received antidepressants and 13.8% received mood stabilizers. CONCLUSION: Based upon the present study data, it is concluded that among all the psychotropic medications, antipsychotics were heavily used and the frequency was found to be significantly high in the case of inpatients compared with outpatients. Such a practice may lead to multiple negative consequences among the Saudi psychiatric patient population. Further, extensive use of sodium valproate in the case of bipolar disorder, and also among females either in childbearing age or during pregnancy is also the cause of concern and warrants logical use. Overall, this study may help in assessing the burden of psychiatric illness within specific patient demographics and might be effectively used to strategically plan health resources allocation, generate new treatment hypothesis, or be used as a source of evidence that could further integrate other observational studies.
format Online
Article
Text
id pubmed-4844432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48444322016-05-03 Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia Alosaimi, Fahad D Alhabbad, Abdulhadi Abalhassan, Mohammed F Fallata, Ebtihaj O Alzain, Nasser M Alassiry, Mohammad Zayed Haddad, Bander Abdullah Neuropsychiatr Dis Treat Original Research OBJECTIVE: To study the pattern of psychotropic medication use and compare this pattern between inpatient and outpatient psychiatric settings in Saudi Arabia. METHOD: This cross-sectional observational study was conducted between July 2012 and June 2014 on patients seeking psychiatric advice at major hospitals in five main regions of Saudi Arabia. Male (n=651) and female (n=594) patients who signed the informed consent form and were currently or had been previously using psychotropic medications, irrespective of the patient’s type of psychiatric diagnosis and duration of the disease, were included. A total of 1,246 patients were found to be suitable in the inclusion criteria of whom 464 were inpatients while 782 were outpatients. RESULTS: Several studied demographic factors have shown that compared with outpatients, inpatients were more likely to be male (P=0.004), unmarried (P<0.001), have less number of children (1–3; P=0.002), unemployed (P=0.001), have a lower family income (<3,000 SR; P<0.001), live in rural communities (P<0.001), have a lower body mass index (P=0.001), and are smokers (P<0.001); however, there were no differences with regard to age or educational levels. The current frequency of use of psychotropic medications in overall patients was antipsychotics (76.6%), antidepressants (41.4%), mood stabilizers (27.9%), and antianxiety (6.2%). However, compared to outpatients, the current use of medications for inpatients was more frequent (93.8% vs 89.9%, P=0.019) with inpatients more likely to be treated with multiple medications (2.1 vs 1.8 medications). A similar trend was observed in the case of antipsychotics, high potency first-generation antipsychotics, second-generation antipsychotics, mood stabilizers, and antianxiety medicines where inpatients were more frequently treated with these medications for all psychiatric diagnoses when compared with outpatients. On the contrary, in the case of antidepressant treatment, an opposite trend was observed with more number of treated outpatients in comparison to inpatients. Among elderly patients, 75.9% received antipsychotics, mainly second-generation formulations (67.2%), whereas only 41% received antidepressants and 13.8% received mood stabilizers. CONCLUSION: Based upon the present study data, it is concluded that among all the psychotropic medications, antipsychotics were heavily used and the frequency was found to be significantly high in the case of inpatients compared with outpatients. Such a practice may lead to multiple negative consequences among the Saudi psychiatric patient population. Further, extensive use of sodium valproate in the case of bipolar disorder, and also among females either in childbearing age or during pregnancy is also the cause of concern and warrants logical use. Overall, this study may help in assessing the burden of psychiatric illness within specific patient demographics and might be effectively used to strategically plan health resources allocation, generate new treatment hypothesis, or be used as a source of evidence that could further integrate other observational studies. Dove Medical Press 2016-04-19 /pmc/articles/PMC4844432/ /pubmed/27143891 http://dx.doi.org/10.2147/NDT.S100405 Text en © 2016 Alosaimi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Alosaimi, Fahad D
Alhabbad, Abdulhadi
Abalhassan, Mohammed F
Fallata, Ebtihaj O
Alzain, Nasser M
Alassiry, Mohammad Zayed
Haddad, Bander Abdullah
Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title_full Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title_fullStr Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title_full_unstemmed Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title_short Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
title_sort patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in saudi arabia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844432/
https://www.ncbi.nlm.nih.gov/pubmed/27143891
http://dx.doi.org/10.2147/NDT.S100405
work_keys_str_mv AT alosaimifahadd patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT alhabbadabdulhadi patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT abalhassanmohammedf patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT fallataebtihajo patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT alzainnasserm patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT alassirymohammadzayed patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia
AT haddadbanderabdullah patternsofpsychotropicmedicationuseininpatientandoutpatientpsychiatricsettingsinsaudiarabia